A patented, better-tolerated iron raw material — distributed by AWS360® across Asia Pacific.
Oxicicledensate is a patented iron citrate developed by Ti Farma in Italy, for which AWS360® is the Asia-Pacific distribution partner. It is engineered for very high bioavailability while preventing iron from being released in the gastric tract — directly targeting the nausea, cramping and constipation that limit conventional iron supplements such as ferrous sulfate, and the poor compliance that often follows.
By avoiding iron release in the stomach, Oxicicledensate sidesteps the side effects that cause many people to stop taking conventional iron.
Designed for very high bioavailability, so more of the iron is available to the body.
Supplied to manufacturers with documentation, and AWS360® can support formulation into your preferred dosage form.
Talk to us about bringing a better-tolerated iron to your market.